Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inhibition of hepatitis C virus 3a genotype entry through Glanthus Nivalis Agglutinin.

Virology journal - 20 May 2011

Ashfaq Usman A, Masoud Muhammad S, Khaliq Saba, Nawaz Zafar, Riazuddin Sheikh

Abstract excerpt

BACKGROUND: Hepatitis C Virus (HCV) has two envelop proteins E1 and E2 which is highly glycosylated and play an important role in cell entry. Inhibition of virus at entry step is an important target to find antiviral drugs against HCV. Glanthus Nivalis Agglutinin (GNA) is a mannose binding lectin which has tendency for specific recognition and reversible binding to the sugar moieties of a wide variety of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Cell Line
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Inhibitory Concentration 50

Share to Mannose-Binding Lectin

Share to Plant Extracts

Share to Virus Internalization

Source

Open in PubMed Open full text

Identifiers

PMID: 21599979
DOI: 10.1186/1743-422X-8-248
PMCID: PMC3117843

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inhibition of hepatitis C virus 3a genotype entry through Glanthus Nivalis Agglutinin.PMID 21599979Read ↗

Inhibition of HCV 3a genotype entry through host CD81 and HCV E2 antibodies.Semantic proximity Read ↗

Additional glycosylation within a specific hypervariable region of subtype 3a of hepatitis C virus protects against virus neutralization.Semantic proximity Read ↗

Antiviral lectins from red and blue-green algae show potent in vitro and in vivo activity against hepatitis C virus.Semantic proximity Read ↗

Anti-viral effect of Indigoferra gerardiana on core protein of HCV and clinical significance of serum markers in chronic HCV genotype 3a patients in district PeshawarSemantic proximity Read ↗

Removal of Clinically Relevant SARS-CoV-2 Variants by An Affinity Resin Containing <i>Galanthus nivalis</i> AgglutininSemantic proximity Read ↗

Safety and Efficacy of Avaren-Fc Lectibody Targeting HCV High-Mannose Glycans in a Human Liver Chimeric Mouse ModelSemantic proximity Read ↗

Monoclonal antibodies against Hepatitis C genotype 3a virus like particle inhibit virus entry in cell culture system.Semantic proximity Read ↗

<em>Microcystis viridis</em> NIES-102 Algae Lectin MVL Interacts with the COVID-19 Spike Protein RBDs via Protein-Protein InteractionSemantic proximity Read ↗

Glycyrrhizin as antiviral agent against Hepatitis C Virus.Semantic proximity Read ↗

Association of the Sialylation of Antibodies Specific to the HCV E2 Envelope Glycoprotein with Hepatic Fibrosis Progression and Antiviral Therapy Efficacy.Semantic proximity Read ↗

Influence of N-linked glycans on intracellular transport of hepatitis C virus E1 chimeric glycoprotein and its role in pseudotype virus infectivity.Semantic proximity Read ↗

<i>Wisteria floribunda</i> agglutinin enhances <i>Zaire ebolavirus</i> entry through interactions at specific N-linked glycosylation sites on the virus glycoprotein complexSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.